Aspen Pharmacare Holdings Ltd
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic ag… Read more
Aspen Pharmacare Holdings Ltd (APN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.040x
Based on the latest financial reports, Aspen Pharmacare Holdings Ltd (APN) has a cash flow conversion efficiency ratio of 0.040x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ZAC3.35 Billion) by net assets (ZAC84.89 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Aspen Pharmacare Holdings Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Aspen Pharmacare Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Aspen Pharmacare Holdings Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aspen Pharmacare Holdings Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Papirfabrikken Invest A/S
CO:PFINV
|
0.024x |
|
KL-Net Corp
KQ:039420
|
0.044x |
|
Ainsworth Game Technology Limited
PINK:AINSF
|
-0.080x |
|
SAURASHTRA CEM B ORD (BSE)
NSE:SAURASHCEM
|
N/A |
|
Shinhan 11th Special Purpose Acquisition Company Co., Ltd.
KQ:452980
|
N/A |
|
Western Acquisition Ventures Corp
NASDAQ:WAVS
|
0.085x |
|
SKY LIGHT HOLDINGS LTD
F:27L
|
N/A |
|
Cell MedX Corp
OTCQB:CMXC
|
0.017x |
Annual Cash Flow Conversion Efficiency for Aspen Pharmacare Holdings Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Aspen Pharmacare Holdings Ltd from 2003 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | ZAC84.89 Billion | ZAC5.16 Billion | 0.061x | -17.16% |
| 2024-06-30 | ZAC84.86 Billion | ZAC6.22 Billion | 0.073x | +14.60% |
| 2023-06-30 | ZAC86.24 Billion | ZAC5.52 Billion | 0.064x | -15.50% |
| 2022-06-30 | ZAC70.94 Billion | ZAC5.37 Billion | 0.076x | -27.16% |
| 2021-06-30 | ZAC65.63 Billion | ZAC6.83 Billion | 0.104x | -12.85% |
| 2020-06-30 | ZAC69.22 Billion | ZAC8.26 Billion | 0.119x | +7.79% |
| 2019-06-30 | ZAC54.21 Billion | ZAC6.00 Billion | 0.111x | -20.96% |
| 2018-06-30 | ZAC50.09 Billion | ZAC7.02 Billion | 0.140x | -7.12% |
| 2017-06-30 | ZAC43.10 Billion | ZAC6.50 Billion | 0.151x | +100.30% |
| 2016-06-30 | ZAC42.50 Billion | ZAC3.20 Billion | 0.075x | -46.84% |
| 2015-06-30 | ZAC34.16 Billion | ZAC4.84 Billion | 0.142x | +6.62% |
| 2014-06-30 | ZAC28.88 Billion | ZAC3.84 Billion | 0.133x | -24.01% |
| 2013-06-30 | ZAC22.80 Billion | ZAC3.99 Billion | 0.175x | +4.59% |
| 2012-06-30 | ZAC17.40 Billion | ZAC2.91 Billion | 0.167x | -9.19% |
| 2011-06-30 | ZAC13.29 Billion | ZAC2.45 Billion | 0.184x | -1.43% |
| 2010-06-30 | ZAC10.89 Billion | ZAC2.03 Billion | 0.187x | -38.39% |
| 2009-06-30 | ZAC4.26 Billion | ZAC1.29 Billion | 0.303x | +54.19% |
| 2008-06-30 | ZAC3.32 Billion | ZAC652.38 Million | 0.197x | -33.71% |
| 2007-06-30 | ZAC2.39 Billion | ZAC708.56 Million | 0.297x | +27.24% |
| 2006-06-30 | ZAC1.73 Billion | ZAC402.21 Million | 0.233x | -59.58% |
| 2005-06-30 | ZAC1.11 Billion | ZAC638.20 Million | 0.577x | +23.31% |
| 2004-06-30 | ZAC1.07 Billion | ZAC498.74 Million | 0.468x | -3.67% |
| 2003-06-30 | ZAC794.98 Million | ZAC385.95 Million | 0.485x | -- |